Status:
COMPLETED
Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)
Lead Sponsor:
NYU Langone Health
Conditions:
Heart Failure
Heart Failure With Reduced Ejection Fraction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF) is a pragmatic, cluster-randomized, three-arm intervention trial that will compare th...
Detailed Description
An estimated 68,000 deaths per year nationwide can be attributed to gaps in care for patients with heart failure and reduced ejection fraction (HFrEF), with the majority being due to lack of mineraloc...
Eligibility Criteria
Inclusion
- Cardiologist visit
- Transthoracic echocardiogram with the most recent EF \>= 40%
Exclusion
- Hypotension: SBP \< 95
- Hyperkalemia: most recent K \> 5.1, or any K \>5.5
- Renal dysfunction: eGFR \< 30
- Ventricular assist device
- Hospice care
- Cardiac amyloid
Key Trial Info
Start Date :
April 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 26 2022
Estimated Enrollment :
2211 Patients enrolled
Trial Details
Trial ID
NCT05275920
Start Date
April 28 2022
End Date
October 26 2022
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016